Suppr超能文献

候选型杀微生物剂在补体病毒调理后对 HIV-1 感染早期步骤的差异活性。

Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization.

机构信息

Université Paris Descartes (Paris V), Laboratoire de Virologie, Hôpital Européen Georges Pompidou, Paris, France.

出版信息

AIDS Res Ther. 2010 Jun 14;7:16. doi: 10.1186/1742-6405-7-16.

Abstract

BACKGROUND

HIV-1 in genital secretions may be opsonized by several molecules including complement components. Opsonized HIV-1 by complement enhances the infection of various mucosal target cells, such as dendritic cells (DC) and epithelial cells.

RESULTS

We herein evaluated the effect of HIV-1 complement opsonization on microbicide candidates' activity, by using three in vitro mucosal models: CCR5-tropic HIV-1JR-CSF transcytosis through epithelial cells, HIV-1JR-CSF attachment on immature monocyte-derived dendritic cells (iMDDC), and infectivity of iMDDC by CCR5-tropic HIV-1BaL and CXCR4-tropic HIV-1NDK. A panel of 10 microbicide candidates [T20, CADA, lectines HHA & GNA, PVAS, human lactoferrin, and monoclonal antibodies IgG1B12, 12G5, 2G12 and 2F5], were investigated using cell-free unopsonized or opsonized HIV-1 by complements. Only HHA and PVAS were able to inhibit HIV trancytosis. Upon opsonization, transcytosis was affected only by HHA, HIV-1 adsorption on iMDDC by four molecules (lactoferrin, IgG1B12, IgG2G5, IgG2G12), and replication in iMDDC of HIV-1BaL by five molecules (lactoferrin, CADA, T20, IgG1B12, IgG2F5) and of HIV-1NDK by two molecules (lactoferrin, IgG12G5).

CONCLUSION

These observations demonstrate that HIV-1 opsonization by complements may modulate in vitro the efficiency of candidate microbicides to inhibit HIV-1 infection of mucosal target cells, as well as its crossing through mucosa.

摘要

背景

艾滋病毒-1 在生殖分泌物中可能被几种分子包裹,包括补体成分。补体包裹的艾滋病毒-1 增强了各种黏膜靶细胞(如树突状细胞[DC]和上皮细胞)的感染。

结果

我们在此通过三种体外黏膜模型评估了 HIV-1 补体包裹对杀微生物候选物活性的影响:CCR5 嗜性 HIV-1JR-CSF 通过上皮细胞的转胞吞作用、未成熟单核细胞衍生的树突状细胞(iMDDC)上的 HIV-1JR-CSF 附着以及 CCR5 嗜性 HIV-1BaL 和 CXCR4 嗜性 HIV-1NDK 对 iMDDC 的感染性。我们使用 10 种杀微生物候选物[T20、CADA、凝集素 HHA 和 GNA、PVAS、人乳铁蛋白和单克隆抗体 IgG1B12、12G5、2G12 和 2F5]组成的面板,对无细胞包裹或补体包裹的未感染 HIV-1 进行了研究。只有 HHA 和 PVAS 能够抑制 HIV 转胞吞作用。在包裹后,只有 HHA 会影响转胞吞作用,四种分子(乳铁蛋白、IgG1B12、IgG2G5 和 IgG2G12)会影响 iMDDC 上的 HIV-1 吸附,五种分子(乳铁蛋白、CADA、T20、IgG1B12 和 IgG2F5)会影响 HIV-1BaL 在 iMDDC 中的复制,两种分子(乳铁蛋白和 IgG12G5)会影响 HIV-1NDK 在 iMDDC 中的复制。

结论

这些观察结果表明,补体对 HIV-1 的包裹可能会调节候选杀微生物剂抑制黏膜靶细胞中 HIV-1 感染以及其穿过黏膜的效率。

相似文献

4
Partial inactivation of CCR5- and CXCR4- tropic HIV-1 by human urine.
Arch Virol. 2011 Dec;156(12):2181-6. doi: 10.1007/s00705-011-1114-9. Epub 2011 Sep 24.
7
Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells.
J Immunol. 2002 Sep 15;169(6):3301-6. doi: 10.4049/jimmunol.169.6.3301.

引用本文的文献

1
The signal peptide as a new target for drug design.
Bioorg Med Chem Lett. 2020 May 15;30(10):127115. doi: 10.1016/j.bmcl.2020.127115. Epub 2020 Mar 17.

本文引用的文献

1
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.
N Engl J Med. 2008 Jul 31;359(5):463-72. doi: 10.1056/NEJMoa0707957.
2
CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor.
Curr HIV Res. 2008 May;6(3):246-56. doi: 10.2174/157016208784324958.
3
SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.
PLoS One. 2008 Jan 23;3(1):e1474. doi: 10.1371/journal.pone.0001474.
4
Complement-HIV interactions during all steps of viral pathogenesis.
Vaccine. 2008 Jun 6;26(24):3046-54. doi: 10.1016/j.vaccine.2007.12.003. Epub 2007 Dec 26.
6
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.
Nat Rev Microbiol. 2007 Aug;5(8):583-97. doi: 10.1038/nrmicro1707.
8
Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides.
BMC Infect Dis. 2006 Oct 16;6:150. doi: 10.1186/1471-2334-6-150.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验